The Food and Drug Administration approved Somaxon's delayed insomnia drug Silenor, sending shares skyrocketing. The company expects to launch the drug in the second half of 2010. Read complete news.
SOMX was alerted multiple times on this blog below $3 for a technical breakout. Good luck to all of us who hold this stock. Trade smart and do your own thorough research.
Current PPS: 9.21
OS: 23.64M
Link to google finance
Thursday, March 18, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment